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PK/PD indices. When the abilities of the indices time within the MSW (T MSW ), AUC 24 /MIC 23 and C max /MIC to predict the selection of resistant bacteria were compared, only the T MSW 24 appeared to be a good predictor of the prevention of resistance for values less than 30%. 25
When the T MSW was higher than 34%, the selection of resistant bacteria occurred less often in 26 thighs initially infected with the low inoculum (11/24, 46 %) than in those infected with the 27 high inoculum (30/36, 80 %) suggesting that the selection of resistant mutants may depend on 28 both the T MSW and inoculum size. The relevance of these results merits further investigation to 29 test different strategies of antibiotic therapy depending on the expected bacterial burden at the 30 infectious site. 31
INTRODUCTION 32
Resistances to fluoroquinolones can occur spontaneously in bacterial populations at a 33 frequency of about 10 -6 to 10 -8 (4) following a stepwise process that involves mutations in 34 genes coding for the targets, DNA gyrase and topoisomerase IV (22, 28). Consequently, if the 35 bacterial load at the infectious site exceeds the inverse of the mutation frequency, it can be 36 presumed that a small resistant subpopulation already coexists with a larger susceptible 37 population, before any antimicrobial treatment is administered. Traditionally, in vitro 38 antimicrobial studies and animal infection models have been used to assess the reduction in 39 the total bacterial population at an infectious site while often ignoring the impact of drug 40 pressure on amplification of the drug-resistant subpopulation (7). Thus, the values of 41 pharmacokinetic/pharmacodynamic indices determined from these experiments were 42 previously selected to predict the bacteria killing and not the selection of resistant bacteria. Streptococcus pneumoniae showed that the selection of resistant bacteria occurred 56 corresponded to the high inoculum, was then diluted 1000 times to obtain the low inoculum. 109
This method to prepare the bacterial inoculum implied that the low inoculum (6.6±0.21 log 10 110 CFU/mL) may have contained resistant mutants in about 40% of the experiments depending 111 on the sampling. 112
Animals. 113
Female Swiss mice (Charles River Laboratories, L'arbresle, France) were used for all studies. 114
All animal procedures were conducted in accordance with accepted human standards of 115 animal care under the agreement number A 31909 for animal experimentation from the 116
French Ministry of Agriculture. 117
Neutropenic mouse thigh infection model. 118
The model used was previously described by Andes and Craig (2). Briefy, female Swiss mice 119 were made neutropenic by intraperitoneal injection of cyclophosphamide (Sigma-Aldrich, 120
Saint Quentin Fallavier, France) at rates of 150 mg/kg and 100 mg/kg of body weight on days 121 1 and 4 respectively. On day 5, the mice were infected by intramuscular injection of 100 µL 122 of the high or low inoculum in each thigh (six thighs per dose, dosing schedule and inoculum 123 size). Marbofloxacin was administered intraperitonally beginning 2 hours after infection. The 124 total doses were 0, 2, 5, 10 and 20 mg/kg marbofloxacin for mice sacrificed at 24 hours and 0, 125 4, 10, 20 and 40 mg/kg marbofloxacin for mice sacrificed at 48 hours after infection. For each 126 dose of marbofloxacin, one group of mice received the total dose in a single administration 127 two hours after infection and another group received the same total dose divided into two or 128 four administrations for mice sacrificed 24 or 48 hours respectively after infection (that 129 corresponded to an administration twice a day). The mice were sacrificed by an 130 minutes and washed twice in 10 mL of NaCl 0.9%. Ten microliters of successive 10-fold 134 dilutions of homogenates were then plated in triplicate on MH drug-free agar plates or on MH 135
plates supplemented with 0.128 µg/mL of marbofloxacin. The colonies were counted after 136 overnight incubation at 37°C. If the bacterial counts were less than 1000 CFU/thigh, 100 µL 137 of the homogenates were plated on agar. If the colonies were too small, incubation was 138 continued for a further 24 hours. The lowest level of detection was 100 CFU/thigh and 139 bacteria were considered eradicated below this level. 140
Pharmacokinetics. 141
Female Swiss mice, satellites from the pharmacodynamic assay, were treated by 142 cyclophosphamide as described above. On the fifth day, the mice were infected with either the 143 high or low inoculum in each thigh and two hours later were administered a single 144 intraperitoneal dose of marbofloxacin. The doses tested were 1 and 5 mg/kg marbofloxacin 145 for the low inoculum and 5 and 20 mg/kg marbofloxacin for the high inoculum. Groups of 3 146 or 4 mice each were anesthetized by intraperitoneal injection of pentobarbital (Dolethal The AUC 24 /MIC for mice sacrificed 48 hours after the infection were determined by dividing 177 the AUC 48 /MIC by 2 to obtain a mean AUC 24 /MIC for each day. 178
RESULTS

182
Susceptibility studies. The MICs of marbofloxacin were 0.008 and 0.256 µg/mL for the 183 susceptible and mutant strains of Escherichia coli respectively. The marbofloxacin MPC was 184 0.256 µg/mL for the susceptible bacteria and corresponded to the MIC of the mutant strain. 185
The Mutant Selection Window (MSW) for the susceptible bacteria was therefore the range of 186 marbofloxacin concentrations between the MIC (0.008 µg/mL) and the MPC (0.256 µg/mL). 187
The term "resistant bacteria" in the present paper should be understood as bacteria growing on 188 0.128 µg/mL marbofloxacin. 189 By assuming dose-proportionality for a given inoculum, the relationships between the dose or 224 AUC 24 /MIC and the reduction of the total bacterial population had exactly the same shape. 225
After 24 hours, we observed the same reduction in the total bacterial population whatever the 226 dose fractionation even though C max were four times lower and T >MIC always longer after 227 fractionated doses than after single doses. As a consequence, no relationship could be found 228 between C max /MIC or T >MIC and the reduction of the total bacterial population. 229
The bacterial populations after 48 hours of exposure to marbofloxacin are shown in Table 4  230 for each inoculum size and each dosing regimen. All control mice (dose 0) and all mice 231 bacterial population was eradicated in some thighs, the frequency of eradication being greater 235 the higher the total dose. However, no clear relationship between reduction of the bacterial 236 populations after 48 hours of exposure to marbofloxacin and the total dose or AUC 24 /MIC 237 was apparent. After single doses associated with higher C max /MIC, the bacterial populations 238 were lower when the initial inoculum was low but higher when the initial inoculum was high 239 than after the same fractionated doses. This strongly suggested that there was no relationship 240 between C max /MIC and the reduction of the total bacterial population. 241
(ii) resistant bacterial populations. When the treatment was started, no resistant bacteria 242 were detected in mice infected with the low inoculum while 2.74±0.41 log 10 CFU of resistant 243 bacteria were present in mice infected with the high inoculum. Twenty-four hours after 244 infection, no resistant bacteria were recovered from the control mice infected with the low 245 inoculum. The proportions of resistant bacteria after 24 hours and 48 hours versus dose are 246 shown in Figure 3 . After 24 hours, with the low inoculum, resistant bacteria in a proportion of 247 3.10 -2 of the total bacteria count were only found in one thigh of a mouse treated with the 248 fractionated dose of 2 mg/kg marbofloxacin ( Figure 3A) . With the high inoculum, the 249 proportion of resistant bacteria in all thighs was always greater than 10 -5 except for four thighs 250 of mice treated with a total dose of 20 mg/kg marbofloxacin in which all resistant bacteria had 251 been eradicated ( Figure 3C ). 252
After 48 hours, no resistant bacteria were detected in mice infected with the low inoculum and 253 treated with single doses of marbofloxacin whereas resistant bacteria were recovered in 46 % 254 of the thighs treated with fractionated doses. The proportion of resistant bacteria ranged from 255
10
-2 to 1 in these thighs ( Figure 3B ). For the high inoculum, resistant bacteria were recovered 256 thighs treated with fractionated doses. The proportions of resistant bacteria were always 258 greater than 10 -2 after single doses and ranged from 10 -6 to 10 -2 after the administration of 259 fractionated doses ( Figure 3D ). As these results indicated a net difference in the selection of 260 resistant bacteria after administrations of single or fractionated doses, it can be presumed that 261 no simple relationship existed between the total dose and the selection of resistant bacteria. production by gram-negative bacteria of endotoxins that were shown to decrease the activity 291 of hepatic metabolism, the renal blood flow and glomerular filtration rate (19). 292
Whatever the regimen, a given total dose of marbofloxacin produced a similar 293 reduction in bacterial population size after 24 hours of treatment, thereby suggesting that the 294 AUC 24 /MIC indice, which was proportional to the total dose, was an appropriate predictor of 295 bacterial killing. In addition, after 48 hours of exposure to marbofloxacin, the only PK/PD 296 indice that was identical for all mice that died after infection with the high inoculum and a 297 treatment with 4 mg/kg marbofloxacin for 48 hours, was also the AUC 24 /MIC since the 298 C max /MIC and T MSW indices differed between mice treated with single doses and mice treated 299 with fractionated doses. In a previous study, an AUC/MIC value of 70 h for gatifloxacin was 300 suggested to have a bacteriostatic effect in a thigh infection of Klebsiella pneumoniae in 301 neutropenic mice (3). In our study, the value of AUC 24 /MPC (corresponding to the 302 AUC 24 /MIC for the resistant bacteria) was 12.1 h for a dose of 4 mg/kg marbofloxacin, which 303 would explain the inability of this dose to slow the growth of the resistant subpopulation 304 enough to prevent death. For the susceptible bacteria, the lowest AUC 24 /MIC observed in our 305 study, i.e. 175 and 387 h for the low and high inoculum respectively, were always sufficient 306 to prevent bacterial growth for 24 hours. For the low inoculum, in which the initial resistant 307 population was assumed to be very small (the probability of the presence of at least one 308 to the emergence of resistance could be 30 % or 80 % depending on the area of the MSW in 336 which drug concentrations fluctuated (10). In our study, we found the same minimal time of 337 30 % associated with the selection of resistance. By relating marbofloxacin exposure to the 338 T MSW , we clearly showed that all mice in which a selection of resistant bacteria occurred after 339 48 hours of marbofloxacin treatment were exposed to a T MSW greater than 34 % for 48 hours 340 irrespective of the inoculum size. Similar results were also reported in a rabbit model of 341 human therapy with Streptococcus pneumoniae and moxifloxacin or gatifloxacin in which 342 selection occurred when the T MSW ranged from 72.5 to 93.5% or when T MSW was greater than 343 45% (8, 9). However, in these latter experiments, the rabbits were infected with a high 344 inoculum containing more than 10 9 CFU/lung. By testing 10 6 and 10 9 CFU/thigh we were able 345 to show that resistance was less frequently selected in the low inoculum than in the high 346 inoculum. After 48 hours of exposure to marbofloxacin, we showed that for a T MSW of 34 % 347 or more, resistant bacteria were selected in 80 % (30/36) of the thighs exposed to the high 348 inoculum but in only 46 % of thighs (11/24) in mice infected by the low inoculum. 349
Interestingly, this percentage of 46 % corresponded to the probability of resistant bacteria 350 being present at the start of treatment with our method of inoculum preparation. The less 351 frequent selection of resistant bacteria in the low inoculum, which remained within the MSW 352 for a long time, seemed to be due to the fact that these bacteria were rarer from the start in the 353 low inoculum. 354
In conclusion, our results fully support the concept of MSW in vivo in a mouse-thigh 355 model since we showed that maintaining the antibiotic concentrations outside the MSW 356 prevented the selection of resistant mutants. We also showed in our pharmacokinetic study in 357 animals infected with either a high or low inoculum, that the size of the bacterial population at 358 the start of treatment could influence both the exposure to the antibiotic and the selection of 359 resistance. Indeed, the PK/PD study indicated that, for approximately the same T MSW , the 360 selection of resistant bacteria occurred less often with the low inoculum than with the high 361 inoculum probably due to the less frequent presence of mutants in the low inoculum. The indices were estimated from kinetic studies performed in mice subjected to a low or high 504 inoculum and treated with 5mg/kg marbofloxacin. 505 Six thighs were tested for each inoculum, each dose and each dosing regimen. Numbers in 518 brackets correspond to the number of thighs in which bacteria were eradicated. There was no 519 clear relationship between the dose and the reduction of the total bacterial population. 520 * all three mice were dead 521 
